The effect of SH-blocking agents on the p-nitrophenylphosphatase activity of intact Ehrlich ascites tumor cells.
D009597:4-Nitrophenylphosphatase / Q000378:metabolism*; D000818:Animals; D001557:Benzenesulfonates / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology*; D002462:Cell Membrane / Q000648:ultrastructure; D002729:Chloromercuribenzoates / Q000494:pharmacology; D004220:Disulfides / Q000494:pharmacology; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D007461:Iodoacetates / Q000494:pharmacology; D008301:Maleimides / Q000494:pharmacology; D051379:Mice; D009439:Neuraminidase; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D013439:Sulfhydryl Reagents / Q000494:pharmacology*
D001557:Benzenesulfonates; D002729:Chloromercuribenzoates; D004220:Disulfides; D007461:Iodoacetates; D008301:Maleimides; D013439:Sulfhydryl Reagents; D004228:Dithionitrobenzoic Acid; D010744:Phosphoric Monoester Hydrolases; D009597:4-Nitrophenylphosphatase; D009439:Neuraminidase; D005033:Ethylmaleimide